Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€2.35

€2.35

-3.820%
-0.092
-3.820%
€12.43
 
28.03.24 / Tradegate WKN: A0LC2W / Symbol: EBS / Name: Emergent Bio / Stock / Biotechnology & Medical Research / Mid Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.

Emergent Biosolutions Inc. Stock

Emergent Biosolutions Inc. took a tumble today and lost -€0.092 (-3.820%).
Based on 2 Buy predictions and 1 Sell predictions the sentiment towards Emergent Biosolutions Inc. is rather balanced.
With a target price of 12 € there is potential for a 410.64% increase which would mean more than doubling the current price of 2.35 € for Emergent Biosolutions Inc..
Our community identified positive and negative aspects for Emergent Biosolutions Inc. stock for the coming years. 1 users see the criterium "Company culture" as a plus for the Emergent Biosolutions Inc. stock. On the other hand our users think that "Worthwhile Investment for the next years" could be a problem in the future.

Pros and Cons of Emergent Biosolutions Inc. in the next few years

Pros
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
?
S********** s********
Cons
?
M***** P*******
?
B****
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of Emergent Biosolutions Inc. vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
Emergent Biosolutions Inc. -3.820% 3.070% -20.554% -71.376% 5.476% -97.081% -94.688%
Ironwood Pharmaceuticals 2.600% -3.049% -42.391% -20.785% -23.558% -11.667% -31.701%
Novocure Ltd 8.330% 12.700% -2.164% -72.841% 1.331% -86.625% -
Iovance Biotherapeutics Inc. 6.800% -3.766% -15.093% 139.363% 75.077% -44.442% -

Comments

Prediction Buy
Perf. (%) -6.97%
Target price 4.582
Change
Ends at 07.03.25

Emergent BioSolutions Inc. (NYSE: EBS) was upgraded by analysts at Benchmark Co. from a "hold" rating to a "buy" rating. They now have a $5.00 price target on the stock.
Ratings data for EBS provided by MarketBeat
Show more

Emergent BioSolutions Inc. (NYSE: EBS) had its "underweight" rating re-affirmed by analysts at JPMorgan Chase & Co..
Ratings data for EBS provided by MarketBeat
Show more

Prediction Buy
Perf. (%) -79.31%
Target price 20.273
Change
Ends at 10.04.24

Emergent BioSolutions Inc. (NYSE: EBS) was upgraded by analysts at Benchmark Co. from a "hold" rating to a "buy" rating. They now have a $22.00 price target on the stock.
Ratings data for EBS provided by MarketBeat
Show more